Zum Hauptinhalt springen

Hepatitiden

23. April 2017 | Hepatitiden

Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).

Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). Marcellin F, Protopopescu C, Esterle L, Wittkop L, Piroth L, Aumaitre H, Bouchaud O, Goujard C, Vittecoq D, Dabis F, Salm…

21. April 2017 | Hepatitiden

WHO sieht dringenden Handlungsbedarf bei Hepatitis

Genf – Rund 325 Millionen Menschen sind nach Schätzungen der Weltgesundheitsorganisation (WHO) mit chronischer Hepatitis B oder Hepatitis C infiziert, aber nur ein Bruchteil von ihnen weiß das. Darauf hat die WHO aufmerksam gemacht…

21. April 2017 | Hepatitiden

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir In Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir In Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials. Jacobson IM, Lawitz E, Gane EJ, Willems BE, Ruane PJ, Nahass RG, Borgia SM, Shafran SD, Workowski KA, Pearlman B…

21. April 2017 | Hepatitiden

EASL - European Association for the Study of the Liver

https://www.easl.eu/

21. April 2017 | Hepatitiden

ILC 2017: European countries restrict access to life-saving treatment for hepatitis C

A review of recent reimbursement data showed considerable variability in access to direct-acting antiviral therapy based on amount of liver scarring and substance use. (European Association for the Study of the Liver, Press Release, 20.04.2017) htt…

21. April 2017 | Hepatitiden

Immunization with a subunit hepatitis C virus vaccine elicits pan-genotypic neutralizing antibodies and intra-hepatic T-cell responses in non-human primates.

Immunization with a subunit hepatitis C virus vaccine elicits pan-genotypic neutralizing antibodies and intra-hepatic T-cell responses in non-human primates. Li D, Wang X, von Schaewen M, Tao W, Zhang Y, Heller B, Hrebikova G, Deng Q, Sun Q, Ploss…

21. April 2017 | Hepatitiden

Efficient replication of blood borne Hepatitis C Virus in human fetal liver stem cells.

Efficient replication of blood borne Hepatitis C Virus in human fetal liver stem cells. Guo, X., Wang, S., Qiu, Z.-G., Dou, Y.-L., Liu, W.-L., Yang, D., Shen, Z.-Q., Chen, Z.-L., Wang, J.-F., Zhang, B.-., Wang, X.-W., Guo, X.-F., Zhang, X.-L., Jin…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten